## ALAB: Astera Labs, Inc. - XLK: Technology

### Executive Summary

VALUE thesis: PEG 0.27 indicates fundamental undervaluation. Quality metrics strong (ROE 18%). Consistent execution (4/4 quarters beat estimates).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($138.69)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Analyst Activity

**Target Signal:** BULLISH (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Northland Capit | $195 | $175 | +11% |
| 2025-11-20 | BNP Paribas Exa | $225 | $0 | 0% |
| 2025-11-17 | Northland Capit | $175 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Northland Capit | main | Outperform |
| 2025-11-20 | BNP Paribas Exa | init | Outperform |
| 2025-11-17 | Northland Capit | up | Outperform |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 38.4% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- FMR, LLC: 14.3% (-2.9%)
- Vanguard Group Inc: 8.1% (+14.1%)
- Blackrock Inc.: 6.7% (+57.6%)
- Alliancebernstein L.: 1.7% (-54.3%)
- Shaw D.E. & Co., Inc: 1.5% (+25.4%)

### Key Risks

1. High beta (2.85) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Elevated short interest (8.5%): bears positioning against stock.
3. Near-term weakness: 6.2% below SMA50 despite long-term uptrend.

### Catalysts

- Momentum building: MRS_20 improving +11.1% over 5 days suggests accumulation.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 0.27 indicates undervaluation relative to growth. Forward P/E 69.7x stretched relative to 33% growth. Quality metrics strong (margin 28%). Balance sheet: strong liquidity (12.8x), low leverage (D/E 0.10). Revenue growth strong at 42% YoY. Analyst sentiment positive (1 raises, avg +11%). Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $27.8B |
| Beta | 1.00 |
| 52W Range | $47.12 - $262.90 |
| Short Interest | 8.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.27 |
| Forward P/E | 69.7 |
| Current P/E | 92.9 |
| YoY Growth | 33.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -7.0% to 4.2% (+11.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 86th percentile. MRS_5 at 6.8% confirms short-term momentum alignment. AM_20 at 5.1% shows strong absolute momentum above own 20MA. Outperforming sector by 5.3pp, stock-specific strength. MACD histogram positive (2.57), confirming momentum. RSI neutral at 53.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.18% (CS: 86) | Strong |
| RSI_14 | 53.3 | Neutral |
| MACD Histogram | 2.57 | Bullish |
| vs SMA20 | 1.051x | Above |
| vs SMA50 | 0.938x | Below |
| vs SMA200 | 1.320x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $165.19
- **Stop Loss:** $138.69 (16.0% risk)
- **Target:** $218.19 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 45
- **Position Value:** $7,433.55
- **Portfolio %:** 7.43%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

### Earnings

**Next:** 2026-02-09 (Est: $0.51)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.39 | $0.49 | +25.6% |
| 2025Q2 | $0.32 | $0.44 | +35.7% |
| 2025Q1 | $0.28 | $0.33 | +16.3% |
| 2024Q4 | $0.26 | $0.37 | +42.8% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*